GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Tax Provision

4basebio (XTER:88Q) Tax Provision : €0.91 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Tax Provision?

4basebio's tax provision for the six months ended in Jun. 2023 was €0.36 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2023 was €0.91 Mil.


4basebio Tax Provision Historical Data

The historical data trend for 4basebio's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Tax Provision Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Tax Provision
0.13 - 0.48 0.90

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Tax Provision Get a 7-Day Free Trial 0.23 0.25 0.35 0.55 0.36

4basebio Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4basebio (XTER:88Q) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines